Clinical Trial

Defining Benchmarks for Gastric Cancer Patients Underwent Minimal Invasive Gastrectomy

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 22, 2025 (before its estimated April 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
The Benchmark-MISGC study was a large-scale retrospective observational study launched by the China Gastric Cancer Surgical Union, aiming to establish the benchmarks of the short- and long-term outcomes for gastric cancer patients who underwent minimal invasive gastrectomy.
Trial Details
NCT Number NCT06938139
Lead Sponsor Fujian Medical University
Conditions Gastric Adenocarcinoma, Surgery, Laparoscopic
Enrollment 90,000 participants
Start Date 2025-03-01
Primary Completion 2025-04-30 (estimated)
Study Completion 2025-04-30 (estimated)
Updated on ClinicalTrials.gov 2025-04-22